Foundation Medical Group
Foundation Medical Group is a physician-led, multi-state behavioral health and addiction medicine practice operating clinics in Virginia, Utah, Georgia, and Texas, delivering psychiatry, therapy, TMS, Spravato, ketamine, and medication-assisted treatment to consumers and institutional referral partners.
- Company typePrivate
- Founded2014
- HeadquartersMidlothian, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Foundation Medical Group does
Foundation Medical Group is a multi-state behavioral health and addiction medicine practice founded in 2014 and headquartered in Midlothian, Virginia, with clinics in Richmond (VA), American Fork (UT), Decatur (GA), and Dallas (TX). It delivers integrated psychiatric evaluation, medication management, talk therapy, and addiction medicine under a four-phase care protocol ("Evaluate, Stabilize, Intervene, Maintain") standardized across locations and supported by a shared medical record. Advanced treatment offerings include Transcranial Magnetic Stimulation via NeuroStar, Spravato (esketamine), ketamine therapy, medication-assisted treatment for opioid and alcohol use disorders (Suboxone, Sublocade, Brixadi, Vivitrol), and adjunctive diagnostics such as QEEG brain mapping and GeneSight pharmacogenomic testing. Leadership comprises board-certified medical directors in each state (Drs. Nardone, Frandsen, Epps, Thompson) plus a lead nurse practitioner, indicating a physician-led operating model.
The practice serves both direct consumers and institutional referral partners. Patient acquisition is driven by phone intake, online booking, same-day or next-day appointment availability, telehealth across all four states, and a Partner/Refer program embedding Foundation providers into hospitals, Partial Hospitalization Programs (PHPs), Intensive Outpatient Programs (IOPs), and crisis centers. The patient base is broad: a 4.9/5 average rating across 487 reviews reflects sustained consumer demand across four distinct regional markets.
Revenue mechanics are predominantly insurance-driven, with the practice accepting roughly 98% of insurance plans including Medicare and Medicaid, supplemented by self-pay for ketamine therapy. The company is privately held with no disclosed funding rounds, parent company, or PE/VC ownership, operating as an independent, physician-led group practice. A sister-clinic relationship with Foundation Wellness extends the brand into adjacent services outside the Foundation Medical Group legal entity.
Foundation Medical Group firmographics
Firmographics- Name
- Foundation Medical Group
- Legal name
- Foundation Medical Group
- Website
- https://foundationmedicalgroup.org
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Foundation Medical Group is a physician-led, multi-state behavioral health and addiction medicine practice operating clinics in Virginia, Utah, Georgia, and Texas, delivering psychiatry, therapy, TMS, Spravato, ketamine, and medication-assisted treatment to consumers and institutional referral partners.
- Ownership category
- akta.pro rank
Foundation Medical Group industry classification
Industry- Product category
- Behavioral Health Services
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Psychiatry & Medication Management Platforms (HLALAEAB)
- akta.pro secondary industry
- Substance Use Recovery & Harm Reduction Support Services (BPAGAEAO)
Keywords
Where Foundation Medical Group is headquartered
LocationHeadquarters
- HQ city
- Midlothian
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Foundation Medical Group business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Insurance-Billed Services: Billable services covered by commercial insurance, Medicare, and Medicaid including psychiatric evaluations, medication management, TMS therapy, Spravato (esketamine), MAT (Suboxone, Subutex, Vivitrol), and talk therapy. TMS and Spravato are covered by most major insurance plans.
- Self-Pay Services: Ketamine therapy is primarily self-pay, though some insurance plans cover a portion. Cash prices offered for uninsured patients.
- Telehealth Services: Virtual psychiatric and addiction care visits billed through insurance or self-pay, expanding access across all four states.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Insurance-covered treatments |
| One time/ perpetual license | Pay-as-you-go | Self-pay treatments (Ketamine) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Foundation Medical Group product offering
Product offeringCore offering
Foundation Medical Group operates an integrated behavioral health platform delivering psychiatric evaluation, medication management, talk therapy, and addiction medicine services across four states. The group specializes in advanced neuromodulation therapies including FDA-cleared TMS (NeuroStar), Spravato (esketamine), and ketamine therapy for treatment-resistant depression, OCD, PTSD, and related conditions, complemented by medication-assisted treatment (Suboxone, Vivitrol) for opioid and alcohol use disorders.
Product overview
Foundation Medical Group operates as an integrated behavioral health platform offering psychiatric care, addiction medicine, and advanced neuromodulation therapies across four states. The core portfolio includes three FDA-cleared advanced treatments (TMS Therapy via NeuroStar, Spravato/esketamine, and Ketamine Therapy) for treatment-resistant mental health conditions, alongside foundational psychiatric services (evaluations, medication management, talk therapy, telehealth). Addiction recovery services encompass MAT/Suboxone, Vivitrol, and buprenorphine products. Diagnostics include QEEG Brain Mapping and GeneSight genetic testing. All services are delivered through a unified care model with one team, one medical chart, and coordinated treatment protocols across Virginia (flagship), Utah, Georgia, and Texas clinic locations.
Differentiator
Problem solved
Functional benefit
Products and services
- TMS Therapy (NeuroStar) Non-invasive, FDA-cleared transcranial magnetic stimulation that uses targeted magnetic pulses to activate areas of the brain affected by depression and OCD. Sessions last about 20 minutes, typically delivered 5x/week for approximately 6 weeks, and are covered by most major insurance plans. Intended for adults with treatment-resistant depression and OCD.
- Spravato (esketamine) FDA-approved nasal spray treatment for treatment-resistant depression administered in-office under direct clinical supervision with two-hour supervised sessions, typically 2x/week for 4 weeks. Covered by most major insurance plans.
- Ketamine Therapy IV and IM ketamine therapy for treatment-resistant depression, chronic PTSD, and severe anxiety, delivered in a monitored clinical setting with 45-60 minute infusions. Primarily self-pay with some partial insurance coverage.
- Psychiatric Evaluation Comprehensive psychiatric assessment including medical history review, mental health evaluation, and development of personalized treatment plans. Typically 60 minutes and available same- or next-day.
- Medication Management Ongoing prescription management and monitoring for psychiatric medications, including dose adjustments and side effect management with regular provider contact.
- Talk Therapy In-person therapy sessions with licensed providers addressing mental health conditions and addiction recovery support.
- Telehealth Virtual healthcare visits enabling remote psychiatric care, follow-up appointments, and medication management via secure video, expanding access across all four states served.
- MAT / Suboxone Medication-assisted treatment using Suboxone (buprenorphine/naloxone) for opioid use disorder, combining medication with counseling support and same-week appointment availability.
- Vivitrol Injection Monthly injectable naltrexone medication administered for alcohol and opioid addiction recovery support.
- QEEG Brain Mapping Quantitative EEG brain mapping service that records and analyzes brain electrical activity to create detailed brain maps identifying patterns linked to mood, attention, addiction, and cognitive conditions, used to guide personalized treatment plans.
- GeneSight Testing Pharmacogenomic testing that analyzes genetic variations to guide medication selection and dosing for psychiatric medications, supporting personalized treatment plans.
Quantifiable outcome
- 82% TMS response rate for treatment-resistant depression (published NeuroStar data)
- +4 more outcomes
Companies that use Foundation Medical Group
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Foundation Medical Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Foundation Medical Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Foundation WellnesscoreSister clinic located adjacent to the American Fork, Utah FMG location. Foundation Wellness provides integrated wellness services including hormone optimization and medical weight management. The clinics coordinate for integrated addiction recovery and mental health care.
- NeuroStar (Advanced Brain Health)coreFDA-cleared TMS therapy technology provider. FMG uses NeuroStar equipment and protocols for transcranial magnetic stimulation treatments for treatment-resistant depression and OCD.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Foundation Medical Group competitors and assessment
Company assessmentEmerging players
- Done: Telehealth psychiatry platform focused on ADHD and related conditions, offering evaluation and ongoing stimulant and non-stimulant medication management. Comparable to FMG's psychiatric medication management on a narrower indication, delivered digitally.
- Brightside Health: Telehealth platform focused on depression and anxiety treatment combining medication management with digital CBT and clinical coaching. Comparable to FMG's treatment-resistant depression positioning but delivered entirely via telehealth.
Direct peers
- CleanSlate Outpatient Addiction Medicine: Multi-state outpatient addiction medicine practice offering physician-led MAT (Suboxone, buprenorphine, Vivitrol) for opioid and alcohol use disorder. Directly comparable to FMG's MAT service line in scope and care model.
- SonderMind: Multi-state outpatient mental health provider combining in-person and telehealth therapy with psychiatric medication management. Comparable to FMG's psychiatric evaluation, medication management, and talk therapy offerings with broader geographic reach.
- Behavioral Health Group (BHG): Multi-state outpatient addiction treatment provider offering physician-led MAT (Suboxone, methadone, buprenorphine) with integrated counseling. Closely comparable to FMG's MAT-driven addiction medicine footprint at greater scale.
- BayMark Health Services: Multi-state operator of medication-assisted treatment (MAT) clinics for opioid and alcohol use disorder, offering Suboxone, buprenorphine, Vivitrol, and counseling. Closest direct peer to FMG's addiction medicine component at greater scale.
- Talkiatry: National psychiatric practice employing board-certified psychiatrists and offering in-person plus telehealth medication management for depression, anxiety, ADHD, and related conditions. Comparable to FMG's psychiatry and medication management services with a heavier telehealth tilt.
- MindPath Care Centers: Multi-state outpatient psychiatric and therapy practice offering evaluation, medication management, and TMS for mood and anxiety disorders. Directly comparable to FMG's integrated outpatient psychiatry model.
- Greenbrook NeuroHealth: Multi-state TMS-focused provider operating dedicated Spravato and TMS treatment centers for treatment-resistant depression and OCD. Directly comparable to FMG's advanced neuromodulation offering with NeuroStar and Spravato.
Broad incumbents
- LifeStance Health: Large publicly-traded outpatient mental health platform operating hundreds of clinics across 30+ states with in-person and telehealth psychiatry, therapy, and medication management. Comparable to FMG in service mix and patient population, but at significantly greater scale and geographic breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Foundation Medical Group social profiles
Digital presenceFoundation Medical Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Foundation Medical Group leadership team
Management profileNumber of profiles
Profiles5 records
Foundation Medical Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Foundation Medical Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Foundation Medical Group
What does Foundation Medical Group do?
Foundation Medical Group operates an integrated behavioral health platform delivering psychiatric evaluation, medication management, talk therapy, and addiction medicine services across four states. The group specializes in advanced neuromodulation therapies including FDA-cleared TMS (NeuroStar), Spravato (esketamine), and ketamine therapy for treatment-resistant depression, OCD, PTSD, and related conditions, complemented by medication-assisted treatment (Suboxone, Vivitrol) for opioid and alcohol use disorders.
Is Foundation Medical Group a public or private company?
Foundation Medical Group is a private company. It is classified as unknown and is currently operating.
When was Foundation Medical Group founded?
Foundation Medical Group was founded in 2014. It employs 11 to 50 people.
Where is Foundation Medical Group based?
Foundation Medical Group is headquartered in Midlothian, United States, in the North America region.
How does Foundation Medical Group make money?
Three revenue lines are on record. Insurance-Billed Services are the primary driver. The others are self-Pay Services and telehealth Services.
Who are Foundation Medical Group's main competitors?
Emerging players on record are Done and Brightside Health. Direct peers are CleanSlate Outpatient Addiction Medicine, SonderMind, Behavioral Health Group (BHG), BayMark Health Services, Talkiatry, MindPath Care Centers and Greenbrook NeuroHealth. LifeStance Health is listed as a broad incumbent.
Does Foundation Medical Group have an API?
No public API is recorded for Foundation Medical Group.
What industry is Foundation Medical Group in?
Foundation Medical Group's product category is Behavioral Health Services. Its primary akta.pro industry code is HLALAEAB, Psychiatry & Medication Management Platforms, with a secondary code of BPAGAEAO, Substance Use Recovery & Harm Reduction Support Services. Its NAICS code is 621420 and its SIC code is 8011.